- ►hematologylibrary.org M Furlan, R Robles, M Solenthaler, M … - Blood, 1997 - bloodjournal.hematologylibrary.org In patients with thrombotic thrombocytopenic purpura (TTP), excessive
intravascular platelet aggregation has been associated with appearance in plasma
of unusually large von Willebrand factor (vWF ) multimers. These extremely ... Cited by 316 - Related articles - BL Direct - All 8 versions
- ►hematologylibrary.org X Zheng, RM Kaufman, LT Goodnough, JE … - Blood, 2004 - bloodjournal.hematologylibrary.org Therapeutic plasma exchange is an effective empiric treatment for thrombotic
thrombocytopenic purpura (TTP), but how therapy affects the level of a
disintegrin and metalloprotease with thrombospondin type 1 motif 13 ... Cited by 160 - Related articles - BL Direct - All 6 versions
- ►hematologylibrary.org F Fakhouri, JP Vernant, A Veyradier, M Wolf, … - Blood, 2005 - bloodjournal.hematologylibrary.org From the Service de Néphrologie, Hôpital Necker, Université Paris V-René
Descartes, Paris, France; Service d'Hématologie, Hôpital de la
Pitié-Salpêtrière, Paris, France; Service d'Hématologie biologique, ... Cited by 118 - Related articles - BL Direct - All 4 versions
- ►hematologylibrary.org - Free from Publisher R Stasi, M Brunetti, E Stipa, S Amadori - Blood, 2004 - bloodjournal.hematologylibrary.org Acquired hemophilia is a rare disorder with an incidence of 0.2 to 1 per million
persons per year. 1,2 It occurs because of spontaneous development of
autoantibodies against the factor VIII (FVIII) molecule, leading to ... Cited by 115 - Related articles - BL Direct - All 5 versions
- ►jbc.org X Zheng, K Nishio, EM Majerus, JE Sadler - Journal of Biological Chemistry, 2003 - ASBMB ADAMTS13 consists of a reprolysin-type metalloprotease domain followed by a
disintegrin domain, a thrombospondin type 1 motif (TSP1), Cys-rich and spacer
domains, seven more TSP1 motifs, and two CUB domains. ADAMTS13 limits ... Cited by 98 - Related articles - BL Direct - All 5 versions
R Yomtovian, W Niklinski, B Silver, R Sarode, … - British journal of haematology, 2004 - interscience.wiley.com Deficiency of von Willebrand factor (VWF) cleaving protease ADAMTS13 has been
demonstrated to be the proximate cause of a subset of thrombotic
microangiopathic haemolytic anaemias (MAHA) typical for thrombotic ... Cited by 97 - Related articles - BL Direct - All 5 versions
B Lammle, JA Kremer Hovinga, L Alberio - Journal of Thrombosis and Haemostasis, 2005 - interscience.wiley.com Summary. This overview summarizes the history of thrombotic thrombocytopenic
purpura (TTP) from its initial recognition in 1924 as a most often fatal disease
to the discovery in 1997 of ADAMTS-13 deficiency as a major risk factor for ... Cited by 83 - Related articles - BL Direct - All 4 versions
JN George, RD Woodson, JE Kiss, K Kojouri, … - Journal of clinical apheresis, 2006 - ouhsc.edu Network With a Systematic Review of Rituximab ... James N. George,1,2* Robert
D. Woodson,3 Joseph E. Kiss,4 Kiarash Kojouri,1 and Sara K. Vesely4 ...
1Hematology-Oncology Section, College of Medicine, The University of ... Cited by 66 - Related articles - View as HTML - BL Direct - All 4 versions
AD Salama, CD Pusey - Nature Clinical Practice Nephrology, 2006 - medscape.com Rituximab, a monoclonal antibody directed against the CD20 molecule found on
pre-B cells and mature B cells (but not on plasma cells), was introduced in the
late 1990s for the treatment of non-Hodgkin's lymphoma. Recently, this ... Cited by 56 - Related articles - BL Direct - All 8 versions
PS Reddy, D Deauna-Limayo, JD Cook, SS … - Annals of hematology, 2005 - Springer Abstract Several reports have defined nonfamilial throm- botic thrombocytopenic
purpura (TTP) as an autoimmune disorder caused by antibodies to von Willebrand's
factor- cleaving protease (vWF-CP). This raises the possibility that ... Cited by 48 - Related articles - All 4 versions
